Traphagen Investment Advisors LLC Lucid Diagnostics Inc. Transaction History
Traphagen Investment Advisors LLC
- $820 Million
- Q2 2025
A detailed history of Traphagen Investment Advisors LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 29,295 shares of LUCD stock, worth $29,295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,295Holding current value
$29,295% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LUCD
# of Institutions
54Shares Held
9.54MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA2.73MShares$2.73 Million0.21% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL1.89MShares$1.89 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA889KShares$888,8740.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny459KShares$459,0650.0% of portfolio
-
Luminus Management LLC Houston, TX457KShares$456,6440.62% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $38.6M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...